10x Genomics (NASDAQ:TXG) Receives Sell (E+) Rating from Weiss Ratings
Weiss Ratings reiterated their sell (e+) rating on shares of 10x Genomics (NASDAQ:TXG – Free Report) in a research note issued to investors on Wednesday morning,Weiss Ratings reports. Several other analysts also recently weighed in on the company. Citigroup decreased their price objective on 10x Genomics from $20.00 to $15.00 and set a “buy” rating […]
Weiss Ratings reiterated their sell (e+) rating on shares of 10x Genomics (NASDAQ:TXG – Free Report) in a research note issued to investors on Wednesday morning,Weiss Ratings reports. Several other analysts also recently weighed in on the company. Citigroup decreased their price objective on 10x Genomics from $20.00 to $15.00 and set a “buy” rating […]
